Abstract
Mucin-producing intraductal papillary neoplasm (adenocarcinoma/adenoma) in the bile duct is becoming recognized as a specific type of neoplasm. Since, it bears a striking similarity to intraductal papillary mucinous neoplasms of the pancreas with regard to its histopathologic features, the term “intraductal papillary mucinous neoplasms of the bile duct” (IPMN-B) is frequently used, although no definite terminology or definition has been decided by World Health Organization. This neoplasm lacks ovarian-like stroma and communicates with the bile ducts, unlike biliary mucinous cystic neoplasm (MCN). On the other hand, malignant IPMN-B is categorized as an intraductal-growth type of intrahepatic cholangiocarcinoma (ICC). In comparison to other types of ICC, such as the mass-forming type and periductal-infiltrating type that have poor resectability and an unfavorable prognosis, malignant IPMN-B can be resected and demonstrates a more favorable prognosis. Meanwhile, unlike biliary MCN that is usually confined in a closed cyst, IPMN-B can spread along the mucosal surface of the bile ducts, and it should be widely resected. Therefore, multimodality assessment is needed to ensure the correct diagnosis of IPMN-B. We herein review the imaging findings of IPMN-B with pathologic correlation.
Similar content being viewed by others
References
Wittekind C, Fischer HP, Ponchon T (2000) Bile duct cystadenoma and cystadenocarcinoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, France, pp 182–183
Zen Y, Fujii T, Itatsu K, et al. (2006) Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol 19:1243–1254
Akiyoshi T, Yamaguchi K, Chijiiwa K, et al. (2003) Cystadenocarcinoma of the liver without mesenchymal stroma: possible progression from a benign cystic lesion suspected by follow-up imagings. J Gastroenterol 38:588–592
Li T, Ji Y, Zhi XT, et al. (2009) A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasms. Clin Gastroenterol Hepatol 7:586–593
Chen TC, Nakanuma Y, Zen Y, et al. (2001) Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34:651–658
Lee SS, Kim MH, Lee SK, et al. (2004) Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer 100:783–793
Ko SF, Chen YS, Ng SH, et al. (1996) Mucin-hypersecreting papillary cholangiocarcinoma presenting as abdominal wall abscess: CT and spiral CT cholangiography. Abdom Imaging 21:222–225
Sakamoto E, Nimura Y, Hayakawa N, et al. (1997) Clinicopathological studies of mucin-producing cholangiocarcinoma. J Hepato-Biliary-Pancreat Surg 4:157–162
Kim H, Kim M, Lee S, et al. (2000) Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy 32:389–393
Shibahara H, Tamada S, Goto M, et al. (2004) Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 28:327–338
Kloppel GKosmahl M (2006) Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol 44:249–250
Zen Y, Sasaki M, Fujii T, et al. (2006) Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct–an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 44:350–358
Paik KY, Heo JS, Choi SH, et al. (2008) Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases. J Surg Oncol 97:508–512
Yeh TS, Tseng JH, Chiu CT, et al. (2006) Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg 244:248–253
Suzuki A, Suzuki S, Sakaguchi T, et al. (2008) A case of mucin-producing cholangiocarcinoma arising from the right hepatic duct. Jpn J Gastroenterol Surg 41:206–211
Isaji S, Kawarada Y, Taoka H, et al. (1999) Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:108–116
Suh KS, Roh HR, Koh YT, et al. (2000) Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 31:12–17
Chen MF, Jan YY, Chen TC (1998) Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. Ann Surg 227:63–69
Kokubo T, Itai Y, Ohtomo K, et al. (1988) Mucin-hypersecreting intrahepatic biliary neoplasms. Radiology 168:609–614
Lim JH, Ko YT, Lee DH, et al. (1990) Oriental cholangiohepatitis: sonographic findings in 48 cases. AJR Am J Roentgenol 155:511–514
Lim J, Yi C, Lim H, et al. (2002) Radiological spectrum of intraductal papillary tumors of the bile ducts. Korean J Radiol 3:57–63
Holtkamp WReis HE (1994) Papillomatosis of the bile ducts: papilloma–carcinoma sequence. Am J Gastroenterol 89:2253–2255
Kim YS, Myung SJ, Kim SY, et al. (1998) Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy 30:763–767
Lee JW, Han JK, Kim TK, et al. (2000) CT features of intraductal intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 175:721–725
Higashi M, Yonezawa S, Ho JJ, et al. (1999) Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 30:1347–1355
Nakanuma Y, Sasaki M, Ishikawa A, et al. (2002) Biliary papillary neoplasm of the liver. Histol Histopathol 17:851–861
Chow L, Ahuja A, Kwong K, et al. (1997) Mucinous cholangiocarcinoma: an unusual complication of hepatolithiasis and recurrent pyogenic cholangitis. Histopathology 30:491–494
Zen Y, Fujii T, Itatsu K, et al. (2006) Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 44:1333–1343
Osako M, Yonezawa S, Siddiki B, et al. (1993) Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 71:2191–2199
Sadler T (1988) Langman’s medical embryology. Plast Reconstr Surg 81:131
Furukawa T, Takahashi T, Kobari M, et al. (1992) The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer 70:1505–1513
Longnecker D, Adler G, Hruban R, et al. (2000) Intraductal papillary-mucinous neoplasms of the pancreas. WHO Classification of Tumors of the Digestive System, pp 237–240
Tanaka M, Chari S, Adsay V, et al. (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32
Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827
Lim JH, Yoon KH, Kim SH, et al. (2004) Intraductal papillary mucinous tumor of the bile ducts. Radiographics 24:53–66 (discussion 66–57)
Lim JH, Jang KT, Choi D (2008) Biliary intraductal papillary-mucinous neoplasm manifesting only as dilatation of the hepatic lobar or segmental bile ducts: imaging features in six patients. AJR Am J Roentgenol 191:778–782
Kim YJ, Yun M, Lee WJ, et al. (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30:1467–1472
Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277–1285
Moon CM, Bang S, Chung JB, et al. (2008) Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 23:759–765
Takanami K, Hiraide T, Kaneta T, et al. (2010) FDG PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts. Clin Nucl Med 35:83–85
Bollow M, Taupitz M, Hamm B, et al. (1997) Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 7:126–132
Cruite I, Schroeder M, Merkle EM, et al. (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195:29–41
Stockberger SM, Sherman S, Kopecky KK (1996) Helical CT cholangiography. Abdom Imaging 21:98–104
Rigo P, Paulus P, Kaschten BJ, et al. (1996) Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23:1641–1674
Anderson C, Rice M, Pinson C, et al. (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90–97
Kim Y, Yun M, Lee W, et al. (2003) Usefulness of 18 F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30:1467–1472
Moon C, Bang S, Chung J, et al. (2008) Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 23:759–765
Fritscher-Ravens A, Bohuslavizki K, Broering D, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277
Sperti C, Bissoli S, Pasquali C, et al. (2007) 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 246:932
Van Beers BE (2008) Diagnosis of cholangiocarcinoma. HPB (Oxford) 10:87–93
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takanami, K., Yamada, T., Tsuda, M. et al. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36, 447–456 (2011). https://doi.org/10.1007/s00261-010-9649-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-010-9649-x